Anna-Liesa Filbert
Overview
Explore the profile of Anna-Liesa Filbert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gazzarata R, Strubin M, Chronaki C, Cangioli G, Saraceno D, Schreier G, et al.
Stud Health Technol Inform
. 2024 Aug;
316:1302-1306.
PMID: 39176620
Innovation in cancer therapy has increased childhood cancer survival rates. However, survivors are still at risk of developing late effects. In the digital transformation of the health sector, the Survivorship...
2.
Saraceno D, Chronaki C, Cangioli G, Filbert A, Muraca M, Berti A, et al.
Stud Health Technol Inform
. 2024 Aug;
316:1280-1284.
PMID: 39176615
The Survivorship Passport (SurPass) for childhood cancer survivors provides a personalized treatment summary together with a care plan for long-term screening of possible late effects. HL7 FHIR connectivity of Electronic...
3.
de Beijer I, van den Oever S, Charalambous E, Cangioli G, Balaguer J, Bardi E, et al.
J Med Internet Res
. 2024 May;
26:e49910.
PMID: 38696248
Background: To overcome knowledge gaps and optimize long-term follow-up (LTFU) care for childhood cancer survivors, the concept of the Survivorship Passport (SurPass) has been invented. Within the European PanCareSurPass project,...
4.
Filbert A, Kremer L, Ladenstein R, Chronaki C, Degelsegger-Marquez A, van der Pal H, et al.
Eur J Cancer
. 2024 Mar;
202:114029.
PMID: 38513384
Background: Childhood cancer survivors (CCS), of whom there are about 500,000 living in Europe, are at an increased risk of developing health problems [1-6] and require lifelong Survivorship Care. There...
5.
de Beijer I, Hardijzer E, Haupt R, Grabow D, Balaguer J, Bardi E, et al.
J Cancer Surviv
. 2024 Mar;
PMID: 38466480
No abstract available.
6.
de Beijer I, Skinner R, Haupt R, Grabow D, Bardi E, Beccaria A, et al.
J Cancer Surviv
. 2023 Dec;
PMID: 38048011
Purpose: Childhood, adolescent and young adult (CAYA) cancer survivors require ongoing surveillance for health problems from the end of cancer treatment throughout their lives. There is a lack of evidence-based...
7.
de Beijer I, Hardijzer E, Haupt R, Grabow D, Balaguer J, Bardi E, et al.
J Cancer Surviv
. 2023 Nov;
PMID: 38015382
Purpose: To identify barriers and facilitators for implementing the Survivorship Passport (SurPass) v2.0 in six long-term follow-up (LTFU) care centres in Europe. Methods: Stakeholders including childhood cancer survivors (CCSs), healthcare...
8.
Wellbrock M, Spix C, Ronckers C, Grabow D, Filbert A, Borkhardt A, et al.
Int J Cancer
. 2023 May;
153(4):742-755.
PMID: 37158619
Childhood cancer is the leading disease-related cause of death among under 15 year olds in Europe. Since primary preventive measures are lacking, improving survival probabilities and long-term well-being remain primary...
9.
van den Oever S, de Beijer I, Kremer L, Alfes M, Balaguer J, Bardi E, et al.
J Cancer Surviv
. 2023 Feb;
18(3):928-940.
PMID: 36808389
Purpose: Long-term follow-up (LTFU) care for childhood cancer survivors (CCSs) is essential to improve and maintain their quality of life. The Survivorship Passport (SurPass) is a digital tool which can...
10.
Chronaki C, Charalambous E, Cangioli G, Schreier G, van den Oever S, van der Pal H, et al.
Stud Health Technol Inform
. 2022 May;
293:161-168.
PMID: 35592976
Compared to the general population, childhood cancer survivors represent a vulnerable population as they are at increased risk of developing health problems, known as late effects, resulting in excess morbidity...